Online citations, reference lists, and bibliographies.
← Back to Search

FDA Drug Approval Summary: Pegaspargase (Oncaspar®) For The First‐Line Treatment Of Children With Acute Lymphoblastic Leukemia (ALL)

Patricia Anne Dinndorf, Joseph Gootenberg, Martin H. Cohen, Patricia Keegan, Richard Pazdur

Cite This
Download PDF
Analyze on Scholarcy
Share